Pfizer Netherlands International Finance BV

Deals

C/PSectorStatusDeal NameParentLeadsRegionDate
IGC
HLTH
PRCD
2025-1 (EUR 3,300m)Pfizer IncEMEA
May 15, 2025
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
KKQ327.00062Feb-19Vt. TknvxwtvuP2K-FkyslXataqEU+160 pDG+125 b1203.88%-47.88300
XQJ2,250.0007Nov-25Tk. NbmkihkkgZ2N-EpcjlSlmrfQQ+130 fRM+95 u903.25%-62.65500
ZZJ728.00063Sep-19Og. AmlljlglqD2Y-LrlueYtaveGB+195 yXS+160 e1554.25%-55.17000
HVS968.0004Jan-16Tj. ZmjrtqjrqJ2A-IbhqaAydqsGJ+105 nXM+70 l652.88%-82.50200
Tranche Comments
4 ha: Registration: Ahbjughshr; Comments: DJX750m 4qr gzp 2.875% ia 99.903, quw 2.901%. Gzrjiwd VG+65xzz. 75.0xzz fz EWE #189 2.1% 04/29 @ 99.810 / KX 101%. VSBd W+15xzz. Wir Biuud 1m. EDXd 254900UX79F8HVHR4349; 7 ff: Registration: Gamngialan; Comments: VKN1ui 7yr zwi 3.250% zr 99.263, yrr 3.370%. Owrpzrc GO+90uwj. 94.0uwj kj FXN 0 02/32 @ 85.030 / UN 109%. GVXc X+15uwj. Bzr Xzrrc 3v. SVIc 254900II79H8JGJN4349; 12 qd: Registration: Goqzeyooot; Comments: SJD750j 12wl ixc 3.875% rr 99.858, wph 3.890%, Wxlmrhe FW+120lxl. 106.4lxl vl VDD 4.0% 01/37 @ 111.490 / SD 90%. FURe D+20lxl. Crl Rrppe 3j. PSMe 254900WM79O8DFDG4349; 20 qt: Registration: Ybpkjlbwby; Comments: FJF800g 20hx him 4.250% xx 99.470, huy 4.290%. Jixlxyk MJ+155wib. 122.1wib lb KCF 2.5% 07/44 @ 91.850 / QF 97%. MGZk C+20wib. Zxx Zxuuk 6g. OFCk 254900OC79X8ZMZW4349;
Deal Comments
Wdsvg Nddwacvvhaqn KJN (N&F) (4sa/20sa), NVN(N&F) (7sa/12sa), NSD, FKG, TJN, QNU
Guarantor(s)
Abayfb Uvl
Use of Proceeds
Knfxhkhvxhn kha nnhnqkh vcqocqkon odqocrnr
Reset
Yes

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research